Grants and Contributions:
Agreement Number:
-
Agreement Value:
$852,300.00
Agreement Date:
Feb 1, 2019 - Jan 31, 2023
Description:
MGMT promoter methylated breast cancer: An opportunity for a targeted treatment with alkylating agent temozolomide in combination with existing breast cancer therapeutics.
Organization:
Canadian Institutes of Health Research
Location:
Calgary, Alberta, CA T2N 1N4
Reference Number:
236-2018-2019-Q4-00094
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient's Legal Name:
Morris, Don G
Research Organization:
University of Calgary